Location preference

Enter your country so we can show you products that are available for you.

Finia in use with two operators in lab

FINIA Fill and Finish System

Automate your cell therapy final formulation processes for precision

A purpose-built, automated system for cell therapy fill and finish

For cell and gene therapy developers, manual processes during the final steps in cell therapy manufacturing can lead to product variability, contamination, and other critical risks. 

But with the Finia™ Fill and Finish System from Terumo Blood and Cell Technologies, developers can finish strong with an automated cell therapy filling device that provides consistent, high-quality results for both suspension cells and adherent cells. 

Video - Demo - 4 min





A side-by-side look: Manual versus automated fill and finish processes

Finia reduces risks at every step …

Unlike solutions that may automate some, but not all, of the cell therapy fill and finish steps, Finia is a functionally closed benchtop system that fully automates every stage, helping to eliminate risks that affect product quality.

  • Automated mixing, cooling, and air removal
  • Automated aliquoting, cryoprotectant addition, and sealing
  • Automated documentation and data management

… And delivers proven performance at scale

As part of our cell therapy technologies suite of solutions, Finia supports manufacturing scale-up, as well.

One study found Finia performed four sequential runs to process a large-volume harvest of T cells, maintaining dose accuracy and cell concentration, viability, functionality, and phenotype in all product bags. The automated process also reduced operator hands-on time by 60%.

Learn more about reducing five key risks during fill and finish

Finia facts: Consistency and quality

  • Consistent environmental temperatures within 3 °C of target to support cell health*
  • Uniform cell concentration within 5%*
  • Post-thaw cell viability of greater than 90%
  • Post-formulation cell viability of greater than 95%
  • Accurate volume control of ± 2 mL, even at high volumes*
  • Effective air removal from final product bags (to less than 2 mL)*
  • Compliant with current Good Manufacturing Practices (cGMP) with electronic data recording and reporting

See inside our approach to fill and finish automation

The Finia system was designed to align with best practices from the International Society for Pharmaceutical Engineering for autologous cell therapies. With its peristaltic pump, low-shear mixing paddles, inbuilt weight check, and active cooling system, Finia delivers.





Plus: Facilitate cGMP compliance with the Cell Processing Application (CPA™)

Finia’s stand-alone, server-based software manages the device and procedure data and automatically transmits data between the system and application during system operation.

Use CPA to:

  • Configure materials and the device
  • Specify processing protocols
  • Define users and permissions
  • Track tubing sets and materials
  • Record alarms and capture electronic data
  • Generate procedure reports

Your partners in cell and gene therapy manufacturing

At Terumo Blood and Cell Technologies, we know that developing a new cell or gene therapy and bringing it to market is a long and complex process. We are here for you throughout the journey with a robust set of solutions, including a platform for cell expansion and expert insights for cell collection optimization.

Help ensure uptime and more with our service packages

Learn about our Veda™ Check solution — installation qualification and operation qualification (IQ/OQ), preventive maintenance, and other service offerings designed to boost operational confidence.

Featured resources

For operator's manuals and Instructions for Use, visit our eIFU website: Terumo.eifu.com. For more information, visit Help.TerumoBCT.com.

Contact us to learn more today — and schedule a demo when you’re ready.

Disclaimers and notes

*Data on file. 

For cell products from healthy T-cell donors.

Of inlet cell viability.

Finia users must qualify/validate the use of Finia and compliance to GMP within their own manufacturing (or laboratory) environment according to their own standard operating procedures (SOPs)/quality system. 

Finia™ and CPA™ are either registered trademarks or trademarks of Terumo BCT, Inc. in the United States and/or other countries. See TerumoBCT.com/trademarks for details.

International Society for Pharmaceutical Engineering is either a registered trademark or a trademark of International Society for Pharmaceutical Engineering, Inc., in the United States and/or other countries. ISCT is either a registered trademark or a trademark of International Society for Cellular Therapy in the United States and/or other countries. BioCentriq is either a registered trademark or a trademark of BIOCENTRIQ, INC. in the United States and/or other countries. Contract Pharma is either a registered trademark or a trademark of RODMAN MEDIA CORP. in the United States and/or other countries.

To top